# Kesin Pharma – FDA Inspection, Jan 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/kesin-pharma/e721e73a-5c98-47c0-be49-6d7f7fec701a
Source feed: FDA_Inspections

> FDA inspection 1227332 of Kesin Pharma, January 19, 2024. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227332
- Company Name: Kesin Pharma
- Inspection Date: 2024-01-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Officers

- [Dorothy P. Kramer](https://www.keypedia.com/people/dorothy-p-kramer/12e3c8b6-6359-43cc-96fd-ba2097225e3d)
- [FDA Associated Person](https://www.keypedia.com/people/nicole-e-knowlton/8e65400f-249f-45fe-96fc-cb00fec6ae39)

Company: https://www.keypedia.com/companies/kesin-pharma/60b8eb12-1b78-43de-89bb-437b1fbe2c3b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
